LRB-5832/1
KP:skw&klm
2019 - 2020 LEGISLATURE
March 26, 2020 - Introduced by Senators Kooyenga, Carpenter, Craig,
Stroebel
and Jacque, cosponsored by Representatives Ott,
Ramthun, Allen,
Brandtjen, Brooks, Dittrich, Murphy, Rohrkaste, Schraa, Wichgers and
Gundrum. Referred to Committee on Economic Development, Commerce and
Trade.
SB927,1,2
1An Act relating to: regulating the sale of certain drugs and medical supplies
2below cost.
Analysis by the Legislative Reference Bureau
This bill exempts pharmaceutical, treatment, and other medical supplies used
for treating COVID-19 from the Unfair Sales Act, also called the minimum markup
law, during the public health emergency declared on March 12, 2020, by executive
order 72.
Under current law, the Unfair Sales Act prohibits retailers and wholesalers
from selling merchandise, including pharmaceutical, treatment, and other medical
supplies, for less than the cost of the merchandise to the retailer or wholesaler.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
SB927,1
3Section 1.
Nonstatutory provisions.
SB927,2,2
4(1) Selling pharmaceutical and medical supplies related to COVID-19 below
5cost. Section 100.30 (3) does not apply to the sale of pharmaceutical, treatment, and
6other medical supplies used for treating COVID-19 during the period covered by the
1public health emergency declared on March 12, 2020, by executive order 72,
2including any extension under s. 323.10.
